American Portfolios Advisors’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-296
Closed -$16K 3564
2022
Q2
$16K Buy
296
+22
+8% +$1.32K ﹤0.01% 2342
2022
Q1
$17.6K Buy
274
+32
+13% +$2.11K ﹤0.01% 2438
2021
Q4
$16.2K Sell
242
-72
-23% -$4.87K ﹤0.01% 2412
2021
Q3
$21.5K Buy
314
+48
+18% +$3.39K ﹤0.01% 2255
2021
Q2
$18.2K Buy
266
+37
+16% +$2.62K ﹤0.01% 2268
2021
Q1
$15.8K Buy
229
+81
+55% +$5.49K ﹤0.01% 2182
2020
Q4
$9.61K Sell
148
-72
-33% -$3.88K ﹤0.01% 2123
2020
Q3
$10.4K Buy
220
+34
+18% +$1.62K ﹤0.01% 1965
2020
Q2
$8.74K Sell
186
-406
-69% -$20K ﹤0.01% 1981
2020
Q1
$26.4K Buy
592
+40
+7% +$2.1K ﹤0.01% 1421
2019
Q4
$32.2K Buy
552
+12
+2% +$714 ﹤0.01% 1534
2019
Q3
$32.4K Buy
540
+453
+521% +$27K ﹤0.01% 1470
2019
Q2
$4.86K Buy
87
+12
+16% +$618 ﹤0.01% 2193
2019
Q1
$4.18K Buy
75
+52
+226% +$2.65K ﹤0.01% 2148
2018
Q4
$1.04K Sell
23
-17
-43% -$933 ﹤0.01% 2253
2018
Q3
$2.63K Buy
40
+7
+21% +$435 ﹤0.01% 2183
2018
Q2
$2.13K Hold
33
﹤0.01% 2186
2018
Q1
$1.83K Hold
33
﹤0.01% 2118
2017
Q4
$1.58K Buy
+33
New +$1.61K ﹤0.01% 2089

Other funds holding IART

American Portfolios Advisors's IART Position: Q3 2022 in Review

American Portfolios Advisors sold out of Integra LifeSciences (IART) in Q3 2022, closing a stake of 296 shares — an estimated $16K sold.

American Portfolios Advisors first reported a position in IART in Q4 2017 and held it in 19 quarters. The position peaked at $32.4K in Q3 2019. 282 funds tracked by Wall St. Rank hold IART as of Q3 2022.

  • American Portfolios Advisors reported no remaining Integra LifeSciences position as of Q3 2022 after selling out during the quarter.
  • American Portfolios Advisors sold 296 Integra LifeSciences shares in Q3 2022, an estimated $16K.
  • American Portfolios Advisors first reported a position in Integra LifeSciences in Q4 2017 and held it in 19 quarters.
  • American Portfolios Advisors's Integra LifeSciences position peaked at $32.4K in Q3 2019.
  • 282 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.